Cargando…

Double Heterozygosity for BRCA1 Pathogenic Variant and BRCA2 Polymorphic Stop Codon K3326X: A Case Report in a Southern Italian Family

Here, we describe a patient with bilateral breast cancer and melanoma, and with a concomitant double variant, namely p.Gln563Ter in BRCA1 and p.Lys3326Ter in BRCA2. The BRCA2 p.Lys3326Ter (K3326X) (rs11571833) mutation identified in our patient is a debated substitution of thymidine for adenine whic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palmirotta, Raffaele, Lovero, Domenica, Stucci, Luigia Stefania, Silvestris, Erica, Quaresmini, Davide, Cardascia, Angela, Silvestris, Franco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796231/ https://www.ncbi.nlm.nih.gov/pubmed/29346284 http://dx.doi.org/10.3390/ijms19010285

Ejemplares similares

SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand
por: Palmirotta, Raffaele, et al.
Publicado: (2018)

Nutrition and Female Fertility: An Interdependent Correlation
por: Silvestris, Erica, et al.
Publicado: (2019)

Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology
por: Palmirotta, Raffaele, et al.
Publicado: (2018)

BRCA1 and BRCA2 mutations in central and southern Italian patients
por: Ottini, Laura, et al.
Publicado: (2000)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017)

Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancer
por: D’Oronzo, Stella, et al.
Publicado: (2019)

K3326X and Other C-Terminal BRCA2 Variants Implicated in Hereditary Cancer Syndromes: A Review
por: Baughan, Scott, et al.
Publicado: (2021)

DEAD-Box Helicase 4 (Ddx4)(+) Stem Cells Sustain Tumor Progression in Non-Serous Ovarian Cancers
por: D’Oronzo, Stella, et al.
Publicado: (2020)

Rare Dihydropyrimidine Dehydrogenase Variants and Toxicity by Floropyrimidines: A Case Report
por: Palmirotta, Raffaele, et al.
Publicado: (2019)

Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context
por: Thompson, Ella R., et al.
Publicado: (2015)

Value of the loss of heterozygosity to BRCA1 variant classification
por: Santana dos Santos, Elizabeth, et al.
Publicado: (2022)

Liquid Biopsy in Cervical Cancer: Hopes and Pitfalls
por: Cafforio, Paola, et al.
Publicado: (2021)

DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors
por: Cives, Mauro, et al.
Publicado: (2019)

Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer.
por: Beckmann, M. W., et al.
Publicado: (1996)

Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients
por: Bang, Yoon Ju, et al.
Publicado: (2022)

Application of “omics” sciences to the prediction of bone metastases from breast cancer: State of the art
por: Gentile, Marica, et al.
Publicado: (2020)

BRCA2 Heterozygosity Delays Cytokinesis in Primary Human Fibroblasts
por: Jonsdottir, Asta Björk, et al.
Publicado: (2009)

A Single nucleotide polymorphism in the ALDH2 gene modifies the risk of esophageal squamous cell carcinoma in BRCA2 p.K3326* carriers
por: Zamani, Neda, et al.
Publicado: (2023)

Double Heterozygosity for Rare Deleterious Variants in the BRCA1 and BRCA2 Genes in a Hungarian Patient with Breast Cancer
por: Madar, László, et al.
Publicado: (2023)

Prognostic value of loss of heterozygosity at BRCA2 in human breast carcinoma.
por: BiÃ¨che, I., et al.
Publicado: (1997)

Mechanisms of increased risk of tumorigenesis in Atm and Brca1 double heterozygosity
por: Wang, Jufang, et al.
Publicado: (2011)

Dual-procedural separation of CTCs in cutaneous melanoma provides useful information for both molecular diagnosis and prognosis
por: Tucci, Marco, et al.
Publicado: (2020)

Immune-related adverse events during anticancer immunotherapy: Pathogenesis and management
por: Stucci, Stefania, et al.
Publicado: (2017)

Pan-Cancer Analysis of BRCA1 and BRCA2 Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of Heterozygosity
por: Sokol, Ethan S., et al.
Publicado: (2020)

Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations
por: Gonzalez, R, et al.
Publicado: (1999)

BRCA1 mutations in southern England.
por: Eccles, D. M., et al.
Publicado: (1998)

BRCA1 and BRCA2 Gene Mutations in Breast/Ovarian Cancer Patients from Central and Southern Italy
por: Ottini, Laura, et al.
Publicado: (1999)

Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection
por: Paradiso, Angelo Virgilio, et al.
Publicado: (2020)

Mapping loss of heterozygosity in normal human breast cells from BRCA1/2 carriers
por: Clarke, C L, et al.
Publicado: (2006)

Double Heterozygosity of BRCA2 and STK11 in Familial Breast Cancer Detected by Exome Sequencing
por: ATAEI-KACHOUEI, Mojgan, et al.
Publicado: (2015)

BRCA1/BRCA2 Mutations Shaped by Ancient Consanguinity Practice in Southern Mediterranean Populations
por: Belaiba, Fadoua, et al.
Publicado: (2018)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
por: Cline, Melissa S., et al.
Publicado: (2018)

Five Italian Families with Two Mutations in BRCA Genes
por: Vietri, Maria Teresa, et al.
Publicado: (2020)

Novel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients
por: Kwong, Ava, et al.
Publicado: (2012)

The Role of Hormonal Replacement Therapy in BRCA Mutated Patients: Lights and Shadows
por: Loizzi, Vera, et al.
Publicado: (2023)

Selection for tandem stop codons in ciliate species with reassigned stop codons
por: Fleming, Ira, et al.
Publicado: (2019)

Mutation Analysis of BRCA1 and BRCA2 in Italian Hereditary and Sporadic Forms of Breast and Ovarian Cancers: Tumor Genotype-Phenotype Correlation in Breast Cancer BRCA-Mutation Carriers
por: Cipollini, G., et al.
Publicado: (1999)

Nonsense Mutation at Codon 63 of the BRCA1 Gene in Japanese Breast Cancer Patients
por: Kijima, George, et al.
Publicado: (1998)

Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.
por: Cleton-Jansen, A. M., et al.
Publicado: (1995)

BRCA1/Trp53 heterozygosity and replication stress drive esophageal cancer development in a mouse model
por: He, Ye, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pdogm9iqt6bat89b8voajf81hc